Error: Could not add to watchlist. X
+ Watchlist

Avantogen Oncology Inc

AVTO:US
OTC US
0.02
USD
0.01
27.80%
As of 8:10 PM EDT 7/25/2016
Open
0.02
Day Range
0.02 - 0.03
Volume
70,811
Previous Close
0.03
52Wk Range
0.00 - 0.06
Open
0.02
Day Range
0.02 - 0.03
Volume
70,811
Previous Close
0.03
52Wk Range
0.00 - 0.06
YTD Return
222.58%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.09
Market Cap (m USD)
1.486
Shares Outstanding (m)
74.282
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Avantogen Oncology, Inc. acquires and develops pharmaceutical compounds focused on the treatment of cancer. The Company has a portfolio of several compounds targeted against various cancers and cancer related diseases. Avantogen seeks to license the compounds at an early stage of development, and then develop and commercialize them by partnering with pharmaceutical companies.
Address
530 South Lake Avenue
Pasadena, CA 91101
United States
Phone
1-917-969-4681
Website
-